form8-k.htm




UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Earliest Event Reported): June 24, 2014


CYTRX CORPORATION
(Exact Name of Registrant as Specified in its Charter)

Delaware
(State or Other Jurisdiction of Incorporation)

000-15327
(Commission File Number)
 
58-1642740
(I.R.S. Employer Identification No.)
11726 San Vicente Boulevard, Suite 650
Los Angeles, California
(Address of Principal Executive Offices)
 
90049
(Zip Code)

(310) 826-5648
(Registrant’s Telephone Number, Including Area Code)

______________________________


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 
 


 

ITEM 5.07                                Submission of Matters to a Vote of Security Holders
 
Annual Meeting of Stockholders
 
The Annual Meeting of stockholders of CytRx was held on June 24, 2014.  The definitive proxy statement relating to the Annual Meeting was filed with the Securities and Exchange Commission on May 1, 2014, and can be viewed at www.sec.gov.
 
At the Annual Meeting, our stockholders acted upon the following proposals:
 
(1)           The election of Steven Kriegsman and Marvin Selter to serve as Class II Directors until the 2017 Annual Meeting of Stockholders;
 
(2)           The advisory approval of the compensation of CytRx’s named executive officers as disclosed in the proxy statement; and
 
(3)           The ratification of the selection of BDO USA, LLP as CytRx’s independent registered public accounting firm for the fiscal year ending December 31, 2014.
 
Voting Results
 
Proposal 1: Messrs. Kriegsman and Selter were re-elected as Class II directors on the following vote:
 
   
“FOR” votes
   
“WITHHELD” votes
 
Steven Kriegsman
    22,889,399       5,954,755  
Marvin Selter
    22,890,616       5,953,538  

 
In addition, there were 15,650,533 broker non-votes in connection with this proposal.
 
Proposal 2:  This proposal was approved with 19,329,791 “FOR” votes, 5,680,516 “AGAINST” votes and 3,833,847 “ABSTAIN” votes.  In addition, there were 15,650,533 broker non-votes in connection with this proposal.
 
Proposal 3:  This proposal was approved with 40,281,864 “FOR” votes, 788,099 “AGAINST” votes and 3,424,724 “ABSTAIN” votes. There were no broker non-votes in connection with this proposal.
 
 


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
CYTRX CORPORATION  
       
Date:    June 27, 2014
By:
/s/ John Y. Caloz  
    John Y. Caloz  
    Chief Financial Officer